RVRC — Revium Rx.

—
OTC · Health Care · Pharmaceuticals · CIK 1839140 ·
Last close
$1.43
Market Cap
$86.84M
52W High
$1.67
52W Low
$0.52
ADV30
0
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Mar 2026 1,480,000 1,480,000 739,000 725,000 7,755,000 920,000 1,599,000

Annual Trend (SEC EDGAR, last 1y)

Revenues vs Net Income (last 1y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 — — 13,449,000 8,296,000 1,415,000 6,881,000 —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$7,755,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
CTOR CITIUS ONCOLOGY, INC. $88.31M $0.83 —
MIST Milestone Pharmaceuticals Inc. $88.66M $0.71 —
RLYB Rallybio Corp $90.23M $16.99 —
EQ Equillium, Inc. $91.31M $1.44 —
RANI Rani Therapeutics Holdings, Inc. $91.42M $0.79 —

News headlines (Yahoo Finance, 1h cache)

Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
2025-10-21 13:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.